123 related articles for article (PubMed ID: 38253397)
1. Risk factors for bacteremia and mortality due to multidrug-resistant Acinetobacter baumannii: a retrospective study.
Yu H; Hu R; Hu X; Lu Y; Yao Y; Su J
Lett Appl Microbiol; 2024 Feb; 77(2):. PubMed ID: 38253397
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.
Zhou H; Yao Y; Zhu B; Ren D; Yang Q; Fu Y; Yu Y; Zhou J
Medicine (Baltimore); 2019 Mar; 98(13):e14937. PubMed ID: 30921191
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study.
Shih MJ; Lee NY; Lee HC; Chang CM; Wu CJ; Chen PL; Ko NY; Ko WC
J Microbiol Immunol Infect; 2008 Apr; 41(2):118-23. PubMed ID: 18473098
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains.
Ye JJ; Huang CT; Shie SS; Huang PY; Su LH; Chiu CH; Leu HS; Chiang PC
PLoS One; 2010 Apr; 5(4):e9947. PubMed ID: 20369056
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
Kuo LC; Lai CC; Liao CH; Hsu CK; Chang YL; Chang CY; Hsueh PR
Clin Microbiol Infect; 2007 Feb; 13(2):196-198. PubMed ID: 17328733
[TBL] [Abstract][Full Text] [Related]
6. The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii.
Ye JJ; Lin HS; Kuo AJ; Leu HS; Chiang PC; Huang CT; Lee MH
J Infect; 2011 Nov; 63(5):351-61. PubMed ID: 21846481
[TBL] [Abstract][Full Text] [Related]
7. Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with
Appaneal HJ; Lopes VV; LaPlante KL; Caffrey AR
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0197521. PubMed ID: 35007134
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
Kim SY; Jung JY; Kang YA; Lim JE; Kim EY; Lee SK; Park SC; Chung KS; Park BH; Kim YS; Kim SK; Chang J; Park MS
J Korean Med Sci; 2012 Aug; 27(8):939-47. PubMed ID: 22876063
[TBL] [Abstract][Full Text] [Related]
9. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Ng TM; Teng CB; Lye DC; Apisarnthanarak A
Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
[TBL] [Abstract][Full Text] [Related]
10. Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship.
Huang PY; Shie SS; Ye JJ; Lin SP; Liu TP; Wu TS; Wu TL; Chuang SS; Cheng MH; Hsieh YC; Huang CT
BMC Infect Dis; 2017 Aug; 17(1):598. PubMed ID: 28854887
[TBL] [Abstract][Full Text] [Related]
11. Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients.
Huang J; Chen EZ; Qu HP; Mao EQ; Zhu ZG; Ni YX; Han LZ; Tang YQ
Chin Med J (Engl); 2013; 126(10):1826-31. PubMed ID: 23673094
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant Acinetobacter baumannii infection among neonates in a neonatal intensive care unit at a medical center in central Taiwan.
Wei HM; Hsu YL; Lin HC; Hsieh TH; Yen TY; Lin HC; Su BH; Hwang KP
J Microbiol Immunol Infect; 2015 Oct; 48(5):531-9. PubMed ID: 25442873
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Anunnatsiri S; Tonsawan P
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients.
Deshwal PR; Fathima R; Aggarwal M; Reddy NS; Tiwari P
Int J Risk Saf Med; 2023; 34(4):337-355. PubMed ID: 37154184
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection.
Shin JA; Chang YS; Kim HJ; Kim SK; Chang J; Ahn CM; Byun MK
Yonsei Med J; 2012 Sep; 53(5):974-84. PubMed ID: 22869481
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Liu CP; Shih SC; Wang NY; Wu AY; Sun FJ; Chow SF; Chen TL; Yan TR
J Microbiol Immunol Infect; 2016 Dec; 49(6):934-940. PubMed ID: 25553994
[TBL] [Abstract][Full Text] [Related]
17. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.
Ogutlu A; Guclu E; Karabay O; Utku AC; Tuna N; Yahyaoglu M
Ann Clin Microbiol Antimicrob; 2014 Jan; 13():7. PubMed ID: 24405720
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital.
Chen Y; Ai L; Guo P; Huang H; Wu Z; Liang X; Liao K
BMC Infect Dis; 2018 Dec; 18(1):614. PubMed ID: 30509192
[TBL] [Abstract][Full Text] [Related]
20. Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome.
Brotfain E; Borer A; Koyfman L; Saidel-Odes L; Frenkel A; Gruenbaum SE; Rosenzweig V; Zlotnik A; Klein M
J Intensive Care Med; 2017 Oct; 32(9):528-534. PubMed ID: 26902255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
